Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.

Joseph G, Kaplan C, Luce J, Lee R, Stewart S, Guerra C, Pasick R.

Public Health Genomics. 2012;15(3-4):172-80. doi: 10.1159/000336419. Epub 2012 Apr 4. Erratum in: Public Health Genomics. 2015;18(1):65-6.

2.

[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].

B├╝rki N.

Ther Umsch. 2010 Jul;67(7):359-66. doi: 10.1024/0040-5930/a000064. Review. German.

PMID:
20577964
3.

Genetic counselling for hereditary predisposition to ovarian and breast cancer.

Mackay J, Szecsei CM.

Ann Oncol. 2010 Oct;21 Suppl 7:vii334-8. doi: 10.1093/annonc/mdq365. Review.

PMID:
20943638
4.

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.

Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R.

Ann Intern Med. 2014 Feb 18;160(4):255-66. Review.

PMID:
24366442
5.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Nelson HD, Huffman LH, Fu R, Harris EL; U.S. Preventive Services Task Force.

Ann Intern Med. 2005 Sep 6;143(5):362-79. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547.

PMID:
16144895
6.

Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.

Khabele D, Runowicz CD.

Curr Womens Health Rep. 2002 Jun;2(3):163-9. Review.

PMID:
12099190
7.

Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.

Shulman LP.

Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003. Review.

PMID:
20494261
8.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
9.

The pros and cons of genetic testing for breast and ovarian cancer risk.

Frank TS, Braverman AM.

Int J Fertil Womens Med. 1999 May-Jun;44(3):139-45. Review.

PMID:
10435912
10.

[Clinical and molecular diagnosis of inherited breast-ovarian cancer].

Chompret A.

J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. Review. French.

11.

Hereditary breast-ovarian cancer: clinical findings and medical management.

Marshall M, Solomon S.

Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. Review.

PMID:
17901820
12.
13.
14.

Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.

Prucka SK, McIlvried DE, Korf BR.

Med Princ Pract. 2008;17(3):173-89. doi: 10.1159/000117790. Epub 2008 Apr 10. Review.

15.

Familial breast and ovarian cancers.

Arai M, Utsunomiya J, Miki Y.

Int J Clin Oncol. 2004 Aug;9(4):270-82. Review.

PMID:
15375703
16.

Genetic counseling for hereditary breast and ovarian cancer among Puerto Rican women living in the United States.

Scherr CL, Vasquez E, Quinn GP, Vadaparampil ST.

Rev Recent Clin Trials. 2014;9(4):245-53. Review.

17.
18.

Genetic Cancer Risk Assessment for Breast Cancer in Latin America.

Chavarri-Guerra Y, Blazer KR, Weitzel JN.

Rev Invest Clin. 2017 Mar-Apr;69(2):94-102. Review.

19.

Risk assessment, genetic counseling, and clinical care for hereditary breast cancer.

Powers J, Stopfer JE.

J Obstet Gynecol Neonatal Nurs. 2014 May-Jun;43(3):361-73. doi: 10.1111/1552-6909.12304. Epub 2014 Apr 1. Review. Erratum in: J Obstet Gynecol Neonatal Nurs. 2014 Nov-Dec;43(6):824.

PMID:
24689498
20.

Weighing the risks. Genetic counseling for hereditary breast and ovarian cancer.

Cummings S.

AWHONN Lifelines. 2001 Jun-Jul;5(3):42-7. Review. No abstract available.

PMID:
11982262

Supplemental Content

Support Center